| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.18 | 0.6 |